{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:22:27Z","timestamp":1791660147468,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["R01-AI14812701A1"],"award-info":[{"award-number":["R01-AI14812701A1"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Interactions of Streptococcus pneumoniae with viruses feature in the pathogenesis of numerous respiratory illnesses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We undertook a case-control study among adults at Kaiser Permanente Southern California between 2015 and 2019. Case patients had diagnoses of lower respiratory tract infection (LRTI; including pneumonia or nonpneumonia LRTI diagnoses), with viral infections detected by multiplex polymerase chain reaction testing. Controls without LRTI diagnoses were matched to case patients by demographic and clinical attributes. We measured vaccine effectiveness (VE) for 13-valent (PCV13) against virus-associated LRTI by determining the adjusted odds ratio for PCV13 receipt, comparing case patients and controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Primary analyses included 13 856 case patients with virus-associated LRTI and 227 887 matched controls. Receipt of PCV13 was associated with a VE of 24.9% (95% confidence interval, 18.4%\u201330.9%) against virus-associated pneumonia and 21.5% (10.9%\u201330.9%) against other (nonpneumonia) virus-associated LRTIs. We estimated VEs of 26.8% (95% confidence interval, 19.9%\u201333.1%) and 18.6% (9.3%\u201327.0%) against all virus-associated LRTI episodes diagnosed in inpatient and outpatient settings, respectively. We identified statistically significant protection against LRTI episodes associated with influenza A and B viruses, endemic human coronaviruses, parainfluenza viruses, human metapneumovirus, and enteroviruses but not respiratory syncytial virus or adenoviruses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among adults, PCV13 conferred moderate protection against virus-associated LRTI. The impacts of pneumococcal conjugate vaccines may be mediated, in part, by effects on polymicrobial interactions between pneumococci and respiratory viruses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiac098","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:09:25Z","timestamp":1647893365000},"page":"498-511","source":"Crossref","is-referenced-by-count":24,"title":["Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study"],"prefix":"10.1093","volume":"227","author":[{"given":"Joseph A","family":"Lewnard","sequence":"first","affiliation":[{"name":"Division of Epidemiology, School of Public Health, University of California, Berkeley , California , USA"},{"name":"Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley , California , USA"},{"name":"Center for Computational Biology, College of Engineering, University of California, Berkeley , California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia J","family":"Bruxvoort","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama at Birmingham , Birmingham, Alabama , USA"},{"name":"Department of Research & Evaluation , Kaiser Permanente Southern California, Pasadena, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vennis X","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Research & Evaluation , Kaiser Permanente Southern California, Pasadena, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R","family":"Grant","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines , Collegeville, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"J\u00f3dar","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines , Collegeville, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Can\u00e9","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines , Collegeville, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D","family":"Gessner","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines , Collegeville, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y","family":"Tartof","sequence":"additional","affiliation":[{"name":"Department of Research & Evaluation , Kaiser Permanente Southern California, Pasadena, California , USA"},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine , Pasadena, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"2023021415121486200_CIT0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","article-title":"Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.","volume":"160","author":"Ruiz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2023021415121486200_CIT0002","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2023021415121486200_CIT0003","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2014Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Centers for Disease Control and Prevention.","year":"2010","journal-title":"MMWR"},{"key":"2023021415121486200_CIT0004","doi-asserted-by":"publisher","first-page":"e1423","DOI":"10.1093\/cid\/ciaa1860","article-title":"Effectiveness of pneumococcal conjugate vaccines against community-acquired alveolar pneumonia attributable to vaccine-serotype Streptococcus pneumoniae among children.","volume":"73","author":"Lewnard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0005","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"2023021415121486200_CIT0006","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/cid\/ciy312","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: a test-negative design.","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0007","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"2023021415121486200_CIT0008","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"2023021415121486200_CIT0009","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1051","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults.","author":"Lewnard","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0010","doi-asserted-by":"publisher","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","article-title":"Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data.","volume":"12","author":"Weinberger","year":"2015","journal-title":"PLoS Med"},{"key":"2023021415121486200_CIT0011","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"2023021415121486200_CIT0012","doi-asserted-by":"crossref","first-page":"e157124","DOI":"10.1172\/JCI157124","article-title":"Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.","volume":"132","author":"Mitsi","year":"2022","journal-title":"J Clin Invest"},{"key":"2023021415121486200_CIT0013","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1164\/rccm.201702-0357OC","article-title":"Acquisition and transmission of Streptococcus pneumoniae are facilitated during rhinovirus infection in families with children.","volume":"196","author":"Karppinen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2023021415121486200_CIT0014","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/INF.0000000000002256","article-title":"High-density bacterial nasal carriage in children is transient and associated with respiratory viral infections\u2014implications for transmission dynamics.","volume":"38","author":"Thors","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2023021415121486200_CIT0015","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1164\/rccm.201602-0220OC","article-title":"Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection.","volume":"194","author":"De Steenhuijsen Piters","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2023021415121486200_CIT0016","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.1093\/cid\/cix100","article-title":"Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of pneumococcal pneumonia among children aged &lt;5 years in the PERCH study.","volume":"64","author":"Baggett","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0017","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/cid\/cix941","article-title":"Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection.","volume":"66","author":"Demuri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0018","doi-asserted-by":"publisher","first-page":"e2680","DOI":"10.1093\/cid\/ciaa1551","article-title":"Influenza-like illness exacerbates pneumococcal carriage in older adults.","volume":"73","author":"Miellet","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10814-9","article-title":"Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine.","volume":"10","author":"De Steenhuijsen Piters","year":"2019","journal-title":"Nat Commun"},{"key":"2023021415121486200_CIT0020","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3201\/eid2511.190157","article-title":"Nasopharyngeal pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness.","volume":"25","author":"Howard","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2023021415121486200_CIT0021","doi-asserted-by":"publisher","first-page":"e141088","DOI":"10.1172\/jci.insight.141088","article-title":"Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine in adults.","volume":"6","author":"Carniel","year":"2021","journal-title":"JCI Insight"},{"key":"2023021415121486200_CIT0022","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nm1077","article-title":"A role for Streptococcus pneumoniae in virus-associated pneumonia.","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"key":"2023021415121486200_CIT0023","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmi.2017.10.006","article-title":"The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: exploratory analysis of the CAPiTA trial.","volume":"24","author":"Huijts","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2023021415121486200_CIT0024","first-page":"273","article-title":"Recommendations of the Immunization Practices Advisory Committee (ACIP) update: pneumococcal polysaccharide vaccine usage\u2014United States.","volume":"33","author":"Immunization Practices Advisory Committee (ACIP).","year":"1984","journal-title":"MMWR"},{"key":"2023021415121486200_CIT0025","first-page":"1069","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices.","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR"},{"key":"2023021415121486200_CIT0026","first-page":"109","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among US adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022.","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR"},{"key":"2023021415121486200_CIT0027","doi-asserted-by":"publisher","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices.","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR"},{"key":"2023021415121486200_CIT0028","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1016\/j.vaccine.2016.09.011","article-title":"Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: a case-population study.","volume":"34","author":"Abadom","year":"2016","journal-title":"Vaccine"},{"key":"2023021415121486200_CIT0029","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/INF.0b013e318280a34b","article-title":"Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study.","volume":"32","author":"Dom\u00ednguez","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2023021415121486200_CIT0030","doi-asserted-by":"crossref","first-page":"e02347","DOI":"10.1128\/mBio.02347-20","article-title":"Pneumococcal conjugate vaccine protection against coronavirus-associated lower respiratory tract infection hospitalization in children living with and without HIV.","volume":"12","author":"Nunes","year":"2021","journal-title":"mBio"},{"key":"2023021415121486200_CIT0031","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1086\/503053","article-title":"Pneumococcal coinfection with human metapneumovirus.","volume":"193","author":"Madhi","year":"2006","journal-title":"J Infect Dis"},{"key":"2023021415121486200_CIT0032","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/529438","article-title":"Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged \u22642 Years: a population-based cohort study.","volume":"46","author":"Stensballe","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0033","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/infdis\/jiab128","article-title":"Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract.","volume":"225","author":"Lewnard","year":"2022","journal-title":"J Infect Dis"},{"key":"2023021415121486200_CIT0034","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017-2018 influenza season.","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0035","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/cid\/ciy775","article-title":"Influenza vaccine effectiveness in the United States during the 2016-2017 season.","volume":"68","author":"Flannery","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0036","author":"Centers for Disease Control and Prevention."},{"key":"2023021415121486200_CIT0037","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jpeds.2008.05.060","article-title":"Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.","volume":"153","author":"Jansen","year":"2008","journal-title":"J Pediatr"},{"key":"2023021415121486200_CIT0038","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jit003","article-title":"Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial.","volume":"207","author":"Omer","year":"2013","journal-title":"J Infect Dis"},{"key":"2023021415121486200_CIT0039","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/ciab307","article-title":"The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011-2018.","volume":"73","author":"Torres","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.vaccine.2019.11.026","article-title":"Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.","volume":"38","author":"Forstner","year":"2020","journal-title":"Vaccine"},{"key":"2023021415121486200_CIT0041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","article-title":"Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.","volume":"75","author":"Pick","year":"2020","journal-title":"Thorax"},{"key":"2023021415121486200_CIT0042","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cid\/cix1066","article-title":"Pneumococcal community-acquired pneumonia detected by serotype-specific urinary antigen detection assays.","volume":"66","author":"Wunderink","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023021415121486200_CIT0043","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among US adults hospitalized for community-acquired pneumonia.","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"key":"2023021415121486200_CIT0044","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/cid\/ciy993","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of all-cause pneumonia in adults aged \u226560 years: a population-based, retrospective cohort study.","volume":"68","author":"Kolditz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"S2","key":"2023021415121486200_CIT0045","doi-asserted-by":"publisher","first-page":"S956","DOI":"10.1093\/ofid\/ofz360.2395","article-title":"2718. Effectiveness of 13-valent pneumococcal conjugate vaccine in US adults hospitalized with pneumonia, 2014\u20132017.","volume":"6","author":"Lessa","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023021415121486200_CIT0046","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cmi.2020.09.011","article-title":"Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.","volume":"27","author":"van Werkhoven","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2023021415121486200_CIT0047","doi-asserted-by":"publisher","first-page":"e45371","DOI":"10.1371\/journal.pone.0045371","article-title":"Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor.","volume":"7","author":"Nishikawa","year":"2012","journal-title":"PLoS One"},{"key":"2023021415121486200_CIT0048","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e3181eaefff","article-title":"Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Myco\u00adbacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study.","volume":"29","author":"Moore","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2023021415121486200_CIT0049","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/aje\/kwy163","article-title":"Measurement of vaccine direct effects under the test-negative design.","volume":"187","author":"Lewnard","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2023021415121486200_CIT0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/EDE.0000000000001366","article-title":"Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines.","volume":"32","author":"Lewnard","year":"2021","journal-title":"Epidemiology"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiac098\/43615289\/jiac098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/227\/4\/498\/49178405\/jiac098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/227\/4\/498\/49178405\/jiac098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:36:58Z","timestamp":1676396218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/227\/4\/498\/6552253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,22]]},"published-print":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac098","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,15]]},"published":{"date-parts":[[2022,3,22]]}}}